✦ LIBER ✦

Recoarctation of the aorta—Eighteen years' clinical experience

✍ Scribed by Carlos Ibarra-Perez; Aldo R. Castaneda; Richard L. Varco; C.Walton Lillehei

Book ID: 115663503
Publisher: Elsevier Science
Year: 1968
Tongue: English
Weight: 125 KB
Volume: 21
Category: Article
ISSN: 0002-9149
DOI: 10.1016/0002-9149(68)90057-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recoarctation of the aorta: Nineteen yea

Recoarctation of the aorta: Nineteen year clinical experience

✍ Carlos Ibarra-Pérez; Aldo R. Castañeda; Richard L. Varco; C. Walton Lillehei 📂 Article 📅 1969 🏛 Elsevier Science 🌐 English ⚖ 693 KB

Posttransplant recoarctation of the aort

Posttransplant recoarctation of the aorta: a twelve year experience

✍ Girish S. Shirali; Constance E. Cephus; Micheal A. Kuhn; Kay K. Ogata; Laura K. 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Angioplasty for recoarctation of the aor

Angioplasty for recoarctation of the aorta-initial and followup

✍ Ziyad Hijazi; John Fahey; Charles S. Kleinman; Howard Weber; William E. Hellenbr 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 333 KB

Recoarctation of the aorta following coa

Recoarctation of the aorta following coarctectomy in the first year of life: A follow-up study

✍ E. Eshaghpour; P.M. Olley 📂 Article 📅 1972 🏛 Elsevier Science 🌐 English ⚖ 417 KB

Eighteen-year experience with echinococc

Eighteen-year experience with echinococcosus of the heart: clinical and echocardiographic features in 14 patients

✍ Khaldoun Ben-Hamda; Faouzi Maatouk; Mohamed Ben-Farhat; Fethi Betbout; Habib Gam 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 460 KB

Carcinoma of the nasopharynx. Eighteen y

Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy

✍ Richard T. Hoppe; Don R. Goffinet; Malcolm A. Bagshaw 📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

From 1956 through 1973, 82 patients with carcinoma of the nasopharynx received high dose megavoltage radiation therapy a t Stanford University. The actuarial disease-free (NED) survival was 62% a t 5 years and 56% a t 10 years. The NED survivals a t 5 years for patients with T I , T2, and T3 lesion